Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06595901 · ClinicalTrials.gov registry record
Mental and Cognitive Health and Physical Activity in the Perioperative Breast Cancer Setting
A clinical trial, sponsored by Washington University School of Medicine.
- Completed
- Registry status
- 42
- Enrollment target
NCT06595901: Completed study, sponsored by Washington University School of Medicine.
NCT06595901 is a clinical trial that has completed, run by Washington University School of Medicine. The registered enrollment target is 42 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06595901 has completed, sponsored by Washington University School of Medicine.
- COMPLETED
- Registry status
- 42 participants
- Enrollment target
Study Summary
This study evaluates the complex relationships between mental health, cognitive function, and physical activity before surgery in patients with stage I-III breast cancer. Most patients with breast cancer experience declines in their mental health, with up to two-thirds of patients reporting symptoms of depression and anxiety. Cancer-related cognitive decline is even more prevalent; 75% of patients with breast cancer report varying degree of loss in mental acuity throughout their cancer experience. Both mental and cognitive health declines are pervasive, lasting anywhere from 5 years to decades after treatment completion. Not only are these declines detrimental to patients' quality of life, but they also increase the risk of cancer-related mortality. Maintaining sufficient levels of physical activity (PA) is important to both prevent breast cancer and improve health post-diagnosis. PA improves anxiety and depressive symptoms during and after treatment. Early intervention with PA prior to or during cancer treatment, or prehabilitation, can avoid or reduce the severity of treatment-related side effects, hospital length of stay, surgical complications, and care costs. Information gained in this study may help researchers learn more about the right time during treatment for delivering lifestyle programs to improve mental and cognitive health.
Primary Outcome
Assessed using an Actigraph hip-worn accelerometer
Interventions
- OTHER Questionnaires
- OTHER Semi-structured interviews
- OTHER Actigraph
- OTHER BrainBaseline application
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 42 participants |
| Start Date | 2022-03-10 |
| Est. Completion | 2023-06-23 |
What the finished NCT06595901 record still lists
NCT06595901 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 42 participants, a relatively small participant target.
The record links to 0 conditions, and to 4 interventions - of which Questionnaires is the first listed.
NCT06595901 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06595901 about?
NCT06595901 is a clinical study titled "Mental and Cognitive Health and Physical Activity in the Perioperative Breast Cancer Setting". This study evaluates the complex relationships between mental health, cognitive function, and physical activity before surgery in patients with stage I-III breast cancer. Most patients with breast cancer experience declines in their mental health, with up to two-thirds of patients reporting symptoms...
What is the current status of trial NCT06595901?
This trial is currently completed. The enrollment target is 42 participants. The study started on 2022-03-10. Estimated completion is 2023-06-23.
What interventions are being tested in trial NCT06595901?
The interventions under investigation include: Questionnaires (OTHER), Semi-structured interviews (OTHER), Actigraph (OTHER), BrainBaseline application (OTHER).
Who is sponsoring clinical trial NCT06595901?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02852213 · 42 participants · Phase 1
A Single-Stage, Adaptive, Open-label, Dose Escalation Safety and Efficacy Study of AADC Deficiency in Pediatric Patients
- NCT03136146 · 42 participants · Phase 2
Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma, Burkitt Lymphoma/Leukemia, or Double-Hit Lymphoma/Leukemia
- NCT03178149 · 42 participants · Phase 1
A Study of the Safety and Tolerability of ASP7317 in Senior Adults Who Are Losing Their Clear, Sharp Central Vision Due to Geographic Atrophy Secondary to Dry Age-related Macular Degeneration
- NCT03663530 · 42 participants · NA
Circadian Misalignment and Energy Balance
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI